Description

Laifemin Capsules №30

Composition

Laifemin Capsules №30 contain a unique blend of natural ingredients, including vitamin B6, magnesium, and chasteberry extract known for their beneficial effects on women’s health.

Mechanism of Action

Laifemin Capsules №30 work by modulating neurotransmitters and hormone receptors in the body, leading to a more balanced hormonal profile and reduced PMS symptoms.

Pharmacological Properties

The natural ingredients in Laifemin Capsules №30 have pharmacological properties that help in regulating hormonal levels and supporting menstrual health.

Indications for Use

Laifemin Capsules №30 are indicated for balancing hormonal levels, supporting menstrual health, and alleviating symptoms of PMS.

Contraindications

Do not use Laifemin Capsules №30 if you are pregnant or nursing without consulting a healthcare provider.

Side Effects

No significant side effects have been reported with the use of Laifemin Capsules №30. However, individual reactions may vary.

Usage Instructions

Recommended dosage: Take 1 capsule daily with a meal or as directed by a healthcare professional.

Benefits Compared to Analogues

Compared to traditional hormone therapy, Laifemin Capsules №30 offer a natural and gentle approach to supporting women’s health without the risks associated with synthetic hormones.

Suitable Patient Groups

Laifemin Capsules №30 are suitable for adult women seeking hormonal balance support. It is not recommended for use in pregnant or nursing women.

Storage and Shelf Life

Store Laifemin Capsules №30 in a cool, dry place away from direct sunlight. Check the expiration date on the packaging for shelf life information.

Packaging Description

Laifemin Capsules №30 are packaged in a container with 30 capsules. The packaging is designed to maintain the product’s quality and integrity.

Clinical Evidence and Proven Effectiveness

Studies have shown that the ingredients in Laifemin Capsules №30, such as chasteberry extract, can help regulate menstrual cycles and reduce PMS symptoms (Milewicz et al., 1993).